E3-ligase Skp2 predicts poor prognosis and maintains cancer stem cell pool in nasopharyngeal carcinoma

Oncotarget

Volumn 5, Issue 14, 2014, Pages 5591-5601

  Wang, Jing ^a   Huang, Ying ^a   Guan, Zhong ^b   Zhang, Jia Liang ^b   Su, Hong Kai ^a   Zhang, Wei ^a   Yue, Cai Feng ^a   Yan, Min ^a   Guan, Su ^c   Liu, Quentin Qiang ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c SOUTH CHINA UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Aldehyde dehydrogenase1 (ALDH1); Cancer stem cell (CSC); Nasopharyngeal carcinoma (NPC); S phase kinase associated protein 2 (Skp2)

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE ISOENZYME 1; S PHASE KINASE ASSOCIATED PROTEIN 2; UNCLASSIFIED DRUG; S PHASE KINASE ASSOCIATED PROTEIN; TUMOR MARKER; UBIQUITIN PROTEIN LIGASE;

ADULT; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STEM CELL; CELL AGING; CELL POPULATION; CELL PROLIFERATION; CELL RENEWAL; CLINICAL FEATURE; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; METASTASIS; NASOPHARYNX CARCINOMA; PREDICTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; ENZYMOLOGY; GENETICS; METABOLISM; NASOPHARYNX TUMOR; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; TUMOR RECURRENCE;

ADULT; CELL PROLIFERATION; FEMALE; HUMANS; MALE; NASOPHARYNGEAL NEOPLASMS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASTIC STEM CELLS; PROGNOSIS; S-PHASE KINASE-ASSOCIATED PROTEINS; TUMOR MARKERS, BIOLOGICAL; UBIQUITIN-PROTEIN LIGASES;

EID: 84906232785     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.2149     Document Type: Article

References (39)

1. Barnes L, Eveson JW, Reichart P, Sidransky D, editors. Pathology and genetics of head and neck tumours. Lyon, France: IARC Press; 2005.
2. Wei W, Ayad NG, Wan Y, Zhang GJ, Kirschner MW, Kaelin WG, Jr.: Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex. Nature 2004, 428(6979):194-198.
3. Carrano AC, Eytan E, Hershko A, Pagano M: SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol 1999, 1(4):193-199.
4. Arbini AA, Greco M, Yao JL, Bourne P, Marra E, Hsieh JT, di Sant'agnese PA, Moro L: Skp2 overexpression is associated with loss of BRCA2 protein in human prostate cancer. Am J Pathol 2011, 178(5):2367-2376.
5. Wei Z, Jiang X, Liu F, Qiao H, Zhou B, Zhai B, Zhang L, Zhang X, Han L, Jiang H, Krissansen GW, Sun X: Downregulation of Skp2 inhibits the growth and metastasis of gastric cancer cells in vitro and in vivo. Tumour Biol 2013, 34(1):181-192.
6. Chan CH, Li CF, Yang WL, Gao Y, Lee SW, Feng Z, Huang HY, Tsai KK, Flores LG, Shao Y, Hazle JD, Yu D, Wei W et al: The Skp2-SCF E3 ligase regulates Akt ubiquitination, glycolysis, herceptin sensitivity, and tumorigenesis. Cell 2012, 149(5):1098-1111.
7. Meng J, Ding Y, Shen A, Yan M, He F, Ji H, Zou L, Liu Y, Wang Y, Lu X, Wang H: Overexpression of PPARgamma can down-regulate Skp2 expression in MDA-MB-231 breast tumor cells. Mol Cell Biochem 2010, 345(1-2):171-180.
8. Huang Y, Tai AW, Tong S, Lok AS: HBV core promoter mutations promote cellular proliferation through E2F1-mediated upregulation of S-phase kinase-associated protein 2 transcription. J Hepatol 2013, 58(6):1068-73.
9. Xu HM, Liang Y, Chen Q, Wu QN, Guo YM, Shen GP, Zhang RH, He ZW, Zeng YX, Xie FY, Kang TB: Correlation of Skp2 overexpression to prognosis of patients with nasopharyngeal carcinoma from South China. Chin J Cancer 2011, 30(3):204-212.
10. Wang J, Guo LP, Chen LZ, Zeng YX, Lu SH: Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line. Cancer Res 2007, 67(8):3716-3724.
11. Reya T, Morrison SJ, Clarke MF, Weissman IL: Stem cells, cancer, and cancer stem cells. Nature 2001, 414(6859):105-111.
12. Visvader JE, Lindeman GJ: Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 2008, 8(10):755-768.
13. Wu A, Luo W, Zhang Q, Yang Z, Zhang G, Li S, Yao K: Aldehyde dehydrogenase 1, a functional marker for identifying cancer stem cells in human nasopharyngeal carcinoma. Cancer Lett 2013, 28; 330(2):181-189.
14. Yu F, Sim AC, Li C, Li Y, Zhao X, Wang DY, Loh KS: Identification of a subpopulation of nasopharyngeal carcinoma cells with cancer stem-like cell properties by high aldehyde dehydrogenase activity. Laryngoscope 2013, 123(8):1903-1911.
15. Su J, Xu XH, Huang Q, Lu MQ, Li DJ, Xue F, Yi F, Ren JH, Wu YP: Identification of cancer stem-like CD44+ cells in human nasopharyngeal carcinoma cell line. Arch Med Res 2011, 42(1):15-21.
16. Janisiewicz AM, Shin JH, Murillo-Sauca O, Kwok S, Le QT, Kong C, Kaplan MJ, Sunwoo JB: CD44(+) cells have cancer stem cell-like properties in nasopharyngeal carcinoma. Int Forum Allergy Rhinol 2012, 2(6):465-470.
17. Lun SW, Cheung ST, Cheung PF, To KF, Woo JK, Choy KW, Chow C, Cheung CC, Chung GT, Cheng AS, Ko CW, Tsao SW, Busson P et al: CD44+ cancer stem-like cells in EBV-associated nasopharyngeal carcinoma. PLoS One 2012, 7(12):e52426.
18. Zhuang HW, Mo TT, Hou WJ, Xiong GX, Zhu XL, Fu QL, Wen WP: Biological characteristics of CD133(+) cells in nasopharyngeal carcinoma. Oncol Rep 2013, 30(1):57-63.
19. Lin HK, Chen Z, Wang G, Nardella C, Lee SW, Chan CH, Yang WL, Wang J, Egia A, Nakayama KI, Cordon-Cardo C, Teruya-Feldstein J, Pandolfi PP: Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence. Nature 2010, 464(7287):374-379.
20. Chan CH, Morrow JK, Li CF, Gao Y, Jin G, Moten A, Stagg LJ, Ladbury JE, Cai Z, Xu D, Logothetis CJ, Hung MC, Zhang S et al: Pharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progression. Cell 2013, 154(3):556-568.
21. Pasanen PA, Eskelinen M, Partanen K, Pikkarainen P, Penttila I, Alhava E: Receiver operating characteristic (ROC) curve analysis of the tumour markers CEA, CA 50 and CA 242 in pancreatic cancer; results from a prospective study. Br J Cancer 1993, 67(4):852-855.
22. Xu HM, Liang Y, Chen Q, Wu QN, Guo YM, Shen GP, Zhang RH, He ZW, Zeng YX, Xie FY, Kang TB: Correlation of Skp2 overexpression to prognosis of patients with nasopharyngeal carcinoma from South China. Chin J Cancer 2011, 30(3):204-212.
23. Fang FM, Chien CY, Li CF, Shiu WY, Chen CH, Huang HY: Effect of S-phase kinase-associated protein 2 expression on distant metastasis and survival in nasopharyngeal carcinoma patients. Int J Radiat Oncol Biol Phys 2009, 73(1):202-207.
24. Zhu L: Skp2 knockout reduces cell proliferation and mouse body size: and prevents cancer? Cell Res 2010, 20(6):605-607.
25. Huang ZX, Yao KT: [Mining gene expression microarray data of nasopharyngeal carcinoma by literature profiling]. Di Yi Jun Yi Da Xue Xue Bao 2004, 24(7):798-801.
26. Campisi J, d'Adda di Fagagna F: Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 2007, 8(9):729-740.
27. Wang J, Han F, Wu J, Lee SW, Chan CH, Wu CY, Yang WL, Gao Y, Zhang X, Jeong YS, Moten A, Samaniego F, Huang P et al: The role of Skp2 in hematopoietic stem cell quiescence, pool size, and self-renewal. Blood 2011, 118(20):5429-5438.
28. Wang J, Han F, Lee SW, Wu J, Chan CH, Zhang X, Gao Y, Su HK, Feng ZZ, Xu DZ, Lin HK: E3-ligase Skp2 regulates beta-catenin expression and maintains hematopoietic stem cell homing. Biochem Biophys Res Commun 2014, 14;445(3):566-71.
29. Cheng Y, Cheung AK, Ko JM, Phoon YP, Chiu PM, Lo PH, Waterman ML, Lung ML: Physiological beta-catenin signaling controls self-renewal networks and generation of stem-like cells from nasopharyngeal carcinoma. BMC Cell Biol 2013, 27;14:44.
30. Ma L, Zhang G, Miao XB, Deng XB, Wu Y, Liu Y, Jin ZR, Li XQ, Liu QZ, Sun DX, Testa JR, Yao KT, Xiao GH: Cancer stem-like cell properties are regulated by EGFR/AKT/beta-catenin signaling and preferentially inhibited by gefitinib in nasopharyngeal carcinoma. FEBS J 2013, 280(9):2027-2041.
31. Shen YA, Lin CH, Chi WH, Wang CY, Hsieh YT, Wei YH, Chen YJ: Resveratrol Impedes the Stemness, Epithelial-Mesenchymal Transition, and Metabolic Reprogramming of Cancer Stem Cells in Nasopharyngeal Carcinoma through p53 Activation. Evid Based Complement Alternat Med 2013; 2013:590393.
32. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisken C et al: The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133(4):704-715.
33. Deng CC, Liang Y, Wu MS, Feng FT, Hu WR, Chen LZ, Feng QS, Bei JX, Zeng YX: Nigericin selectively targets cancer stem cells in nasopharyngeal carcinoma. Int J Biochem Cell Biol 2013, 45(9):1997-2006.
34. Zhou W, Yue C, Deng J, Hu R, Xu J, Feng L, Lan Q, Zhang W, Ji D, Wu J, Liu Q, Liu A: Autophagic protein Beclin 1 serves as an independent positive prognostic biomarker for non-small cell lung cancer. PLoS One 2013, 15; 8(11):e80338.
35. Fiore C, Bailey D, Conlon N, Wu X, Martin N, Fiorentino M, Finn S, Fall K, Andersson SO, Andren O, Loda M, Flavin R: Utility of multispectral imaging in automated quantitative scoring of immunohistochemistry. J Clin Pathol 2012, 65(6):496-502.
36. Huang W, Hennrick K, Drew S: A colorful future of quantitative pathology: validation of Vectra technology using chromogenic multiplexed immunohistochemistry and prostate tissue microarrays. Hum Pathol 2013, 44(1):29-38.
37. Chan CH, Lee SW, Li CF, Wang J, Yang WL, Wu CY, Wu J, Nakayama KI, Kang HY, Huang HY, Hung MC, Pandolfi PP, Lin HK: Deciphering the transcriptional complex critical for RhoA gene expression and cancer metastasis. Nat Cell Biol 2010, 12(5):457-467.
38. Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, Kawamura MJ, Wicha MS: In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 2003, 17(10):1253-1270.
39. Bouska A, Lushnikova T, Plaza S, Eischen CM: Mdm2 promotes genetic instability and transformation independent of p53. Mol Cell Biol 2008, 28(15):4862-4874.